S&P 500 Futures Flat in Premarket Trading; IonQ, Quantinuum Lead

Dow Jones
Yesterday

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, IonQ Inc. (IONQ) was up 11.7% in pre-market trading, and Quantinuum Inc. (QNT) was up 6.5%.

PACS Group Inc. (PACS), Lennar Corp. Cl B $(LEN.B)$, and Advanced Drainage Systems Inc. (WMS) were all posting gains of at least 5%. In early trading, Archrock Inc. $(AROC)$ and Immunovant Inc. $(IMVT)$ had posted declines, falling 7.9% and 7.4%, respectively.

Meanwhile S&P 500 futures were up 0.02%, with futures for the Dow Jones Industrial Average falling 0.05%. The Cboe Volatility Index futures were down 2.79%.

In commodities news, Brent crude oil futures were up 0.49%, and gold futures were down 0.65%. Bitcoin was down 0.77% to $85,565.

The 10-Year Treasury yield climbed to 4.979%.

In the previous regular trading session, the S&P 500 remained unchanged, while the Dow was down 0.36%. In Asia overnight, China's Shanghai Composite Index was down 0.39%.

In afternoon trading, stocks in Europe are down, with the STOXX Europe 600 Index declining 0.31% and the FTSE 100 Index dropping 0.04% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10